Our vision is that we will never bow down to disease and will never be satisfied with the treatment outcomes, thereby constantly working on their improvement. Swiss Medica started in 2011 in Lugano, when a group of scientists, doctors-inventors and a Swiss businessman met at the conference
Our primary task is to make your own cells treat your own body. We use advanced technology to activate dormant cells (adipose mesenchymal stem cells) to differentiate into the cells we need, and then they replace the damaged cells. Symptoms become less obvious and disappear.
Our specialty lies in the following fields:
Multiple Sclerosis COPD Diabetes Type 2 Diabetes Type 1 Stroke Asthma / Allergies / Sinusitis Cerebral Palsy Liver Disease / Cirrhosis Amyotrophic Lateral Sclerosis / ALS Autism Treatment
Arthritis / Arthrosis / Osteochondrosis Parkinson Disease Treatment Dementia Alzheimer Disease Arterial Hypertension Chronic fatigue syndrome Obesity Lyme Disease Crohn’s Disease
Case Study – Primary Progressive Multiple Sclerosis Case Study – Secondary Progressive Multiple Sclerosis Case Study – Relapsing Multiple Sclerosis
Statistical Report COPD Treatment with Stem Cells Statistical Report Multiple Sclerosis Treatment with Stem Cells
Swiss Medica – What the Media Is Saying
Shaun Lawrence’s story about his Multiple Sclerosis treatment was published in UK’s Whitchurch Herald. You can find out more here.